Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future

by Walid Shalata, Binil Mathew Jacob, Abed Agbarya
Published 2021-08-01

Cetuximab in treatment of metastatic colorectal cancer: background and clinical observation

by A. D. Darenskaya, N. V. Dobrova, B. M. Medvedeva
Published 2018-11-01

A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation

by Meifang Li, Jilong Yang, Lenghe Zhang, Sanfang Tu, Xuan Zhou, Ze Tan, Weijun Zhou, Yanjie He, Yuhua Li
Published 2019-05-01

Afectación metastásica pericárdica en cáncer de pulmón de célula no pequeña

by Miguel Borregón Rivill, Katherin Aly Martínez Barroso, Ruth Álvarez Cabellos, Elia Martínez Moreno
Published 2020-07-01

CDK4/6 inhibitor palbociclib overcomes acquired resistance to third‐generation EGFR inhibitor osimertinib in non‐small cell lung cancer (NSCLC)

by Qiong Qin, Xiaoqing Li, Xingmei Liang, Lili Zeng, Jing Wang, Linlin Sun, Diansheng Zhong
Published 2020-09-01

EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma

by Shiang-Fu Huang, Huei-Tzu Chien, Sou-De Cheng, Wen-Yu Chuang, Chun-Ta Liao, Hung-Ming Wang
Published 2017-08-01

Evaluation of epidermal growth factor receptor mutations based on mutation specific immunohistochemistry in non-small cell lung cancer: A preliminary study

by Deepali Jain, Sobuhi Iqbal, Ritika Walia, Prabhat Malik, Sunu Cyriac, Sandeep R Mathur, Mehar C Sharma, Karan Madan, Anant Mohan, Ashu Bhalla, Sushmita Pathy, Lalit Kumar, Randeep Guleria
Published 2016-01-01

Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis

by Guotian Pei, Mingwei Li, Xianjun Min, Qiang Liu, Dasheng Li, Yingshun Yang, Shuai Wang, Xiaoyu Wang, Huina Wang, Huanqing Cheng, Shanbo Cao, Yuqing Huang
Published 2021-05-01

Protein Kinase C as a Therapeutic Target in Non-Small Cell Lung Cancer

by Mohammad Mojtaba Sadeghi, Mohamed F. Salama, Yusuf A. Hannun
Published 2021-05-01

Concurrent chemotherapy and first‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first‐line treatme...

by Ziyi Xu, Xuezhi Hao, Lin Lin, Junling Li, Puyuan Xing
Published 2021-08-01

Epidermal growth factor receptor pathway as therapeutic development in head and neck cancers: present and future

by Chancellor E. Donald, Luis E. Raez, Edgardo S. Santos
Published 2011-12-01

Cloning and Expression of Truncated Protein of Epidermal Growth Factor-1 (EGFR-1) in Pichia Pastoris Yeast Host

by Javad Zavar-Reza, Nader Khaleghi, Ali Hatami, Masumeh Heidari, Reza Mansuri-Majumerd, Mohammad Hasan Sheikhha, Majid Mojarrad
Published 2016-02-01

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10)

by Vázquez S, Casal J, Afonso Afonso FJ, Fírvida JL, Santomé L, Barón F, Lázaro M, Pena C, Amenedo M, Abdulkader I, González-Arenas C, Fachal L, Vega A
Published 2016-02-01

Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance

by Etienne Giroux-Leprieur, Adrien Costantini, Vivianne W. Ding, Biao He
Published 2018-09-01

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

by Edurne Arriola, Ramón García Gómez, Pilar Diz, Margarita Majem, Maite Martínez Aguillo, Javier Valdivia, Alfredo Paredes, José Miguel Sánchez-Torres, Sergio Peralta Muñoz, Isidoro Barneto, Vanesa Gutierrez, Jesús Manuel Andrade Santiago, Francisco Aparisi, Dolores Isla, Santiago Ponce, David Vicente Baz, Angel Artal, Mariluz Amador, Mariano Provencio
Published 2018-01-01

Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TK...

by Paolo Bironzo, Maria Lucia Reale, Tessa Sperone, Fabrizio Tabbò, Andrea Caglio, Angela Listì, Francesco Passiglia, Massimo Di Maio, Luisella Righi, Federico Bussolino, Giorgio V. Scagliotti, Silvia Novello
Published 2021-05-01

Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma

by Teng Li, Xiaocong Pang, Junyun Wang, Junyun Wang, Shouzheng Wang, Yiying Guo, Ning He, Puyuan Xing, Junling Li
Published 2021-05-01

A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation

by Tomoyo Oguri, Shinji Sasada, Sachiko Seki, Saori Murata, Yumi Tsuchiya, Kota Ishioka, Saeko Takahashi, Reishi Seki, Shigemichi Hirose, Ryohei Katayama, Morio Nakamura
Published 2021-01-01

PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs

by Nadiia Lypova, Susan M. Dougherty, Lilibeth Lanceta, Jason Chesney, Yoannis Imbert-Fernandez
Published 2021-07-01

Psorachromene Suppresses Oral Squamous Cell Carcinoma Progression by Inhibiting Long Non-coding RNA GAS5 Mediated Epithelial-Mesenchymal Transition

by Tong-Hong Wang, Tong-Hong Wang, Tong-Hong Wang, Yann-Lii Leu, Yann-Lii Leu, Yann-Lii Leu, Chin-Chuan Chen, Chin-Chuan Chen, Tzong-Ming Shieh, Jang-Hau Lian, Chi-Yuan Chen, Chi-Yuan Chen
Published 2019-11-01